[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6065 Introduced in House (IH)]

<DOC>






114th CONGRESS
  2d Session
                                H. R. 6065

 To amend the Public Health Service Act with respect to the prevention 
and treatment of the use of synthetic recreational drugs, and for other 
                               purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           September 15, 2016

 Ms. Velazquez (for herself, Mr. Serrano, Ms. Clarke of New York, Mr. 
   Jeffries, and Mr. Engel) introduced the following bill; which was 
            referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
 To amend the Public Health Service Act with respect to the prevention 
and treatment of the use of synthetic recreational drugs, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Synthetic Drug Overdose Prevention 
and Education Act''.

SEC. 2. SYNTHETIC RECREATIONAL DRUGS.

    Title III of the Public Health Service Act is amended by inserting 
after section 317T of such Act (42 U.S.C. 247b-22) the following:

``SEC. 317U. SYNTHETIC RECREATIONAL DRUGS.

    ``(a) Study.--Not later than 1 year after the date of enactment of 
this Act, the Director of the Centers for Disease Control and 
Prevention (in this section referred to as the `Director') shall--
            ``(1) complete a study on strategies for preventing and 
        treating the use of synthetic recreational drugs (as identified 
        pursuant to subsection (b)(3)), including best rehabilitation 
        practices; and
            ``(2) submit a report to the Congress on the results of 
        such study.
    ``(b) Database.--
            ``(1) In general.--The Secretary, in coordination with the 
        Administrator of the Drug Enforcement Administration, shall 
        establish and maintain a database of synthetic recreational 
        drugs.
            ``(2) Availability.--The Secretary shall make the 
        information in the database under paragraph (1) publicly 
        available for use in preventing and treating the use of 
        synthetic recreational drugs.
            ``(3) Identification of synthetic recreational drugs.--
        Beginning not later than 90 days after the date of the 
        enactment of the Synthetic Drug Overdose Prevention and 
        Education Act, for purposes of this section, the Secretary 
        shall specify (and update as necessary) a list of substances, 
        each of which shall satisfy the following criteria:
                    ``(A) The substance is an analogue of a controlled 
                substance (as defined in section 102 of the Controlled 
                Substances Act).
                    ``(B) The substance is not marketed as a drug (as 
                defined in section 201 of the Federal Food, Drug, and 
                Cosmetic Act).
                    ``(C) The substance is determined by the Secretary 
                to be marketed for recreational human use, irrespective 
                of claims to the contrary in the labeling and promotion 
                of the substance.
        Each substance identified on the most recent list specified by 
        the Secretary pursuant to this paragraph is referred to in this 
        section as a `synthetic recreational drug'.
    ``(c) Cannabimimetic Agents.--
            ``(1) Outreach campaign.--Not later than 1 year after the 
        date of enactment of this Act, the Director, in collaboration 
        with the Administrator of the Substance Abuse and Mental Health 
        Services Administration, the Director of the National Institute 
        on Drug Abuse, the Director of the National Institutes of 
        Health, and the Administrator of the Drug Enforcement 
        Administration, shall develop and implement a national outreach 
        campaign to educate law enforcement personnel, State and local 
        agencies, health care professionals, community health 
        organizations, parents, youth, and other community members 
        about preventing and treating the use of cannabimimetic agents.
            ``(2) Grants.--
                    ``(A) In general.--The Director may make grants to 
                Federally-qualified health centers for programs to 
                increase public awareness about, and prevent and treat, 
                the use of cannabimimetic agents.
                    ``(B) Maximum amount.--The maximum amount of a 
                grant under this section shall be $100,000.
                    ``(C) Authorization of appropriations.--To carry 
                out this paragraph, there is authorized to be 
                appropriated $2,500,000 for the period of fiscal years 
                2017 through 2019.
    ``(d) Definitions.--In this section:
            ``(1) The term `cannabimimetic agent' has the meaning given 
        to that term in section 202(d)(2) of the Controlled Substances 
        Act.
            ``(2) The term `Federally-qualified health center' has the 
        meaning given to such term in section 1861(aa) of the Social 
        Security Act.''.
                                 <all>
